Page last updated: 2024-08-16

salmeterol xinafoate and Arrhythmia

salmeterol xinafoate has been researched along with Arrhythmia in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's3 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baumgartner, RA; Cheng, H; Grogan, DR; Hanrahan, JP; Morganroth, J; Wilson, A; Zimetbaum, PJ1
Baumgartner, RA; Donohue, JF; Goodwin, E; Grogan, DR; Hanania, NA; Hanrahan, JP; Sciarappa, KA1
Martínez, MA; Perpiñá, M; Román, P; Sánchez, L; Soler, JJ1
Calderaro, F; Cazzola, M; Di Perna, F; Imperatore, A; Imperatore, F; Matera, MG; Salzillo, A1
Calderaro, F; Califano, C; Cazzola, M; Di Pema, F; Donner, CF; Matera, MG; Vinciguerra, A1
Chervinsky, P; Gross, G; Pearlman, DS; Prillaman, B; Shah, T; Stricker, W; Weinstein, S; Woodring, A1

Trials

5 trial(s) available for salmeterol xinafoate and Arrhythmia

ArticleYear
Arrhythmias in patients with chronic obstructive pulmonary disease (COPD): occurrence frequency and the effect of treatment with the inhaled long-acting beta2-agonists arformoterol and salmeterol.
    Medicine, 2008, Volume: 87, Issue:6

    Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Aged; Albuterol; Arrhythmias, Cardiac; Atrial Fibrillation; Dose-Response Relationship, Drug; Double-Blind Method; Ethanolamines; Female; Formoterol Fumarate; Heart Rate; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Tachycardia; Treatment Outcome

2008
Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and tolerance.
    Therapeutic advances in respiratory disease, 2008, Volume: 2, Issue:2

    Topics: Albuterol; Arrhythmias, Cardiac; Bronchitis; Bronchodilator Agents; Ethanolamines; Female; Forced Expiratory Volume; Formoterol Fumarate; Humans; Ipratropium; Male; Middle Aged; Myocardial Ischemia; Nebulizers and Vaporizers; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections; Salmeterol Xinafoate; Tremor

2008
Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia.
    Chest, 1998, Volume: 114, Issue:2

    Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Albuterol; Arrhythmias, Cardiac; Cross-Over Studies; Electrocardiography, Ambulatory; Ethanolamines; Female; Formoterol Fumarate; Heart; Heart Rate; Humans; Hypoxia; Lung Diseases, Obstructive; Male; Middle Aged; Potassium; Respiratory Function Tests; Safety; Salmeterol Xinafoate; Single-Blind Method

1998
Oral bambuterol compared to inhaled salmeterol in patients with partially reversible chronic obstructive pulmonary disease.
    European journal of clinical pharmacology, 1999, Volume: 54, Issue:11

    Topics: Administration, Inhalation; Administration, Oral; Adult; Aged; Albuterol; Arrhythmias, Cardiac; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Forced Expiratory Flow Rates; Forced Expiratory Volume; Heart Rate; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Salmeterol Xinafoate; Terbutaline; Time Factors; Tremor

1999
Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 1999, Volume: 82, Issue:3

    Topics: Adolescent; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adult; Albuterol; Androstadienes; Anti-Asthmatic Agents; Arrhythmias, Cardiac; Asthma; Bronchodilator Agents; Child; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Fluticasone; Forced Expiratory Volume; Humans; Male; Middle Aged; Peak Expiratory Flow Rate; Pilot Projects; Safety; Salmeterol Xinafoate; Severity of Illness Index; Treatment Outcome

1999

Other Studies

1 other study(ies) available for salmeterol xinafoate and Arrhythmia

ArticleYear
Risk factors of emergency care and admissions in COPD patients with high consumption of health resources.
    Respiratory medicine, 2004, Volume: 98, Issue:4

    Topics: Administration, Inhalation; Aged; Albuterol; Arrhythmias, Cardiac; Bronchodilator Agents; Case-Control Studies; Emergency Treatment; Forced Expiratory Volume; Health Resources; Hospitalization; Humans; Male; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quality of Life; Regression Analysis; Risk Factors; Salmeterol Xinafoate; Surveys and Questionnaires; Vital Capacity

2004